A · US market
Agilent Technologies Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$47.08bnFinancials dated 30 April 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$1.41bn
- Latest-quarter run-rate earnings
- US$1.36bn
- Latest fiscal-year earnings
- US$1.30bn
- Trailing revenue
- US$7.23bn
- Latest-quarter run-rate revenue
- US$7.34bn
- Latest fiscal-year revenue
- US$6.95bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- PHO · Invesco Water Resources ETF4.20% weight · Holdings dated 19 August 2026
- CSIEX · Calvert Equity Fund Class A3.90% weight · Holdings dated 30 June 2026
- FSMEX · Fidelity Select Medical Technology and Devices Portfolio3.21% weight · Holdings dated 31 May 2026
- GDOC · Goldman Sachs Future Health Care Equity ETF2.77% weight · Holdings dated 31 May 2026
- TMED · T. Rowe Price Health Care ETF2.61% weight · Holdings dated 30 June 2026
- PAXLX · Impax Large Cap Fund Individual Investor Class2.60% weight · Holdings dated 30 June 2026
- EAALX · Eaton Vance-Atlanta Capital Focused Growth Fund Class A2.46% weight · Holdings dated 30 June 2026
- MDEV · First Trust Indxx Medical Devices ETF2.37% weight · Holdings dated 30 June 2026
- FTCS · First Trust Capital Strength ETF2.20% weight · Holdings dated 30 June 2026
- FAMWX · FAM Value Fund Institutional Class2.14% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 April 2026. Informational research, not investment advice.